Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclaris Therapts
(NQ:
ACRS
)
1.270
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.270
Bid (Size)
1.180 (1)
Ask (Size)
1.270 (2)
Prev. Close
1.270
Today's Range
1.270 - 1.270
52wk Range
0.5902 - 8.275
Shares Outstanding
71,344,557
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
July 23, 2024
Via
Benzinga
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
July 11, 2024
Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices.
Via
MarketBeat
Performance
YTD
+20.95%
+20.95%
1 Month
-4.51%
-4.51%
3 Month
+10.43%
+10.43%
6 Month
+5.83%
+5.83%
1 Year
-83.16%
-83.16%
More News
Read More
Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
July 08, 2024
Via
Benzinga
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 24, 2024
Via
Benzinga
Aclaris Therapeutics: Q4 Earnings Insights
February 27, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Aclaris Therapeutics
January 11, 2024
Via
Benzinga
Breaking Down Aclaris Therapeutics: 6 Analysts Share Their Views
December 18, 2023
Via
Benzinga
ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
Via
FinancialNewsMedia
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
Via
Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today?
January 16, 2024
Via
Benzinga
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
January 10, 2024
Via
Benzinga
Crude Oil Falls 1%; Amarin Shares Spike Higher
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial
January 10, 2024
Via
Benzinga
Dow Surges 100 Points; PriceSmart Earnings Top Views
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study
December 20, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.